Mersana Therapeutics (MRSN) Insider Trading & Ownership → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free mrsn Stock Alerts $2.58 +0.01 (+0.39%) (As of 05/16/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Mersana Therapeutics (NASDAQ:MRSN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$132,074.68 Get MRSN Insider Trade Alerts Want to know when executives and insiders are buying or selling Mersana Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MRSN Insider Buying and Selling by Quarter Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. Mersana Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/16/2024Anna ProtopapasDirectorSell29,399$2.71$79,671.29 1/16/2024Ashish MandeliaCAOSell5,025$2.71$13,617.75 1/16/2024Brian DeschuytnerCFOSell9,327$2.71$25,276.17 1/16/2024Tushar MisraSVPSell3,357$2.71$9,097.47 10/26/2023Mohan BalaSVPSell1,912$1.13$2,160.56 8/17/2023Tushar MisraSVPSell1,908$1.18$2,251.44 (Data available from 1/1/2013 forward) MRSN Insider Trading Activity - Frequently Asked Questions Who is on Mersana Therapeutics's Insider Roster? The list of insiders at Mersana Therapeutics includes Alejandra Carvajal, Andrew A F Hack, Anna Protopapas, Arvin Yang, Ashish Mandelia, Brian Deschuytner, Lawrence M. Alleva, Mohan Bala, Timothy B Lowinger, and Tushar Misra. Learn more on insiders at MRSN. What percentage of Mersana Therapeutics stock is owned by insiders? 12.50% of Mersana Therapeutics stock is owned by insiders. Learn more on MRSN's insider holdings. Which Mersana Therapeutics insiders have been buying company stock? The following insider purchased MRSN shares in the last 24 months: Andrew A F Hack ($1,703,917.32). How much insider buying is happening at Mersana Therapeutics? Insiders have purchased a total of 512,541 MRSN shares in the last 24 months for a total of $1,703,917.32 bought. Which Mersana Therapeutics insiders have been selling company stock? The following insiders have sold MRSN shares in the last 24 months: Alejandra Carvajal ($15,342.16), Anna Protopapas ($179,237.33), Arvin Yang ($12,679.66), Ashish Mandelia ($34,138.25), Brian Deschuytner ($54,728.11), Mohan Bala ($2,160.56), and Tushar Misra ($27,318.73). How much insider selling is happening at Mersana Therapeutics? Insiders have sold a total of 85,470 Mersana Therapeutics shares in the last 24 months for a total of $325,604.80 sold. More Insider Trading Tools from MarketBeat Related Companies: ANNX Insider Trading BMEA Insider Trading HRTX Insider Trading KRRO Insider Trading LXRX Insider Trading CRBP Insider Trading ESPR Insider Trading ANRO Insider Trading PEPG Insider Trading AMRN Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:MRSN) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mersana Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.